Skylight Health Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Skylight Health Group şirketinin son birkaç yıldaki performansına ilişkin yeterli veri bulunmamaktadır.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Healthcare Sektör Büyümesi	8.5%
Gelir büyüme oranı	n/a
Özkaynak getirisi	n/a
Net Marj	n/a
Son Kazanç Güncellemesi	30 Sep 2022

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Skylight Health Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

OTCPK:SLHG.F Gelir, gider ve kazançlar (CAD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 22	54	-26	36
30 Jun 22	42	-27	37
31 Mar 22	33	-27	36
31 Dec 21	27	-22	31
30 Sep 21	8	-23	24
30 Jun 21	3	-20	17
31 Mar 21	0	-14	11
31 Dec 20	1	-12	9
30 Sep 20	13	-8	9
30 Jun 20	14	-9	11
31 Mar 20	14	-10	12
31 Dec 19	13	-11	13
30 Sep 19	13	-8	13
30 Jun 19	11	-7	12
31 Mar 19	11	-6	11
31 Dec 18	11	-4	10
30 Sep 18	9	-2	7
31 Dec 17	0	-1	1
31 Dec 16	0	0	0

Kaliteli Kazançlar: SLHG.F yüksek kalitede kazançlar sağlayıp sağlamadığını belirlemek için yeterli veri yok.

Büyüyen Kar Marjı: SLHG.F 'nin kâr marjlarının geçen yıl boyunca iyileşip iyileşmediğini belirlemek için yeterli veri yok.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: SLHG.F 'un son 5 yılda yıllık kazanç büyüme oranının pozitif olup olmadığını belirlemek için yeterli veri yok.

Büyüme Hızlandırma: SLHG.F 'in geçmiş yıl kazanç büyümesinin 5 yıllık ortalamayla karşılaştırılmasına yetecek veri yok.

Kazançlar vs. Sektör: SLHG.F şirketinin geçen yılki kazanç büyümesinin Healthcare sektör ortalamasını aşıp aşmadığını belirlemek için yeterli veri yok.

Özkaynak Getirisi

Yüksek ROE: SLHG.F hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( 0% ) sahiptir.

Skylight Health Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Skylight Health Group Inc. to Report Q3, 2022 Results on Nov 16, 2022

Second quarter 2022 earnings released: CA$0.13 loss per share (vs CA$0.16 loss in 2Q 2021)

Skylight Health Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Skylight Health Group Inc. to Report Q1, 2022 Results on May 16, 2022

Full year 2021 earnings released: CA$0.60 loss per share (vs CA$0.43 loss in FY 2020)

Third quarter 2021 earnings released: CA$0.09 loss per share (vs CA$0.065 loss in 3Q 2020)

Recent updates

Securities of Skylight Health Group Inc. to Be Delisted from NEX

Skylight Health Group Inc. Announces the Resignation of Tom Brogan as Board of Directors

Skylight Health Group Inc. announced that it has received CAD 6.762 million in funding

Skylight Health Group Inc. to Report Q3, 2022 Results on Nov 16, 2022

Skylight Health Group Inc. announced that it expects to receive CAD 6.861 million in funding

Nasdaq Suspends Skylight Health Group

Skylight Health Group Inc. announced that it has received CAD 2.355 million in funding

Second quarter 2022 earnings released: CA$0.13 loss per share (vs CA$0.16 loss in 2Q 2021)

Skylight Health Group reports Q2 results

Skylight Health Group Inc. to Report Q2, 2022 Results on Aug 15, 2022

Skylight Health Group Inc. announced that it expects to receive CAD 2 million in funding

Skylight Health Group announces C$2M private placement

Skylight Health Group Inc. Announces Board Changes

Skylight Health announces re-appointment of co-founder Qureshi as president

Skylight Health Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Skylight Health Group Inc. Appoints Farooq Akhter as Interim Chief Financial Officer, Effective June 15, 2022

Skylight Health Group Inc. to Report Q1, 2022 Results on May 16, 2022

Skylight Health Group Inc. (TSXV:SLHG) executed a definitive agreement to acquire NeighborMD.

Skylight Health Group Inc. announced delayed 20-F filing

Full year 2021 earnings released: CA$0.60 loss per share (vs CA$0.43 loss in FY 2020)

High number of new directors

Co-Founder recently bought US$64k worth of stock

Skylight Health Group: Rapidly Growing National Primary Healthcare Platform

Third quarter 2021 earnings released: CA$0.09 loss per share (vs CA$0.065 loss in 3Q 2020)

No longer forecast to breakeven

Second quarter 2021 earnings released: CA$0.11 loss per share (vs CA$0.04 loss in 2Q 2020)

Skylight Health Group Inc. (TSXV:SLHG) acquired ACO Partners, Inc.

Skylight Health Group Inc. (TSXV:SLHG) acquired Doctors Center Inc.

Skylight Health Group Inc. Announces Management Changes

Skylight Health Group Inc. (TSXV:SHG) entered into Letters of Intent to acquire 3 Independent Primary Care Practices in the United States.

Skylight Health Group Inc. Appoints Andrew Elinesky as Chief Financial Officer

Skylight Health Group Inc. (TSXV:SHG) acquired River City Medical Associates.

Skylight Health Announces Executive Changes

Skylight Health Names Paul Kulas Senior Vice President of Operations

Skylight Health Group Inc. Begins Patient Onboarding for GatherMed Roll-Out with Insurable Reimbursement Revenue

Skylight Health Group Inc. Appoints Grace Mellis to the Board of Directors

CB2 Insights Inc. (CNSX:CBII) completed the acquisition of assets of APEX Family Medical.

Skylight Health Group Inc. (CNSX:SHG) completed the acquisition of Assets of Healthcare Resources Management LLC.

Skylight Health Group Inc. has completed a Follow-on Equity Offering in the amount of CAD 12 million.

Skylight Health Partners with Gathermed to Launch Remote Patient Monitoring Covered Through Insurance for Patients with Hypertension

Skylight Health Group Inc. (CNSX:SHG) entered into a letter of intent to acquire Assets of Healthcare Resources Management LLC CAD 1.03 million.

CB2 Insights Inc. has completed a Follow-on Equity Offering in the amount of CAD 5.0008 million.

CB2 Insights Inc. (CNSX:CBII) entered into a letter of intent to acquire assets of APEX Family Medical for CAD 2.3 million.

CB2 Insights Inc. (CNSX:CBII) acquired Maverick County Medical Family Center for CAD 0.98 million.

CB2 Insights Inc. announced that it has received CAD 5.138046 million in funding from Merida Capital Partners, LLC and other investors

CB2 Insights Inc. announced that it expects to receive CAD 3 million in funding from Merida Capital Partners, LLC

CB2 Insights Inc. to Report Q2, 2020 Results on Aug 31, 2020

CB2 Insights Inc. to Report Q1, 2020 Results on Jul 14, 2020

CB2 Insights Inc. Auditor Raises 'Going Concern' Doubt

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin